Penumbra (PEN) Net Cash Flow (2014 - 2026)
Penumbra (PEN) posted quarterly Net Cash Flow of -$36.0 million for Q2 2026, down 181.44% year-over-year from $44.2 million in Q2 2025, and down 166.11% quarter-over-quarter from $54.4 million in Q1 2026.
Penumbra (PEN) Net Cash Flow (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Net Cash Flow for 13 consecutive years, with -$36.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Cash Flow fell 181.44% year-over-year to -$36.0 million; the TTM figure through Jun 2026 stood at -$216.3 million (down 262.37% YoY), while the FY2025 annual figure was -$139.4 million, down 187.62% from the prior year.
- Net Cash Flow eased to -$36.0 million in Q2 2026 per PEN's latest filing, from $54.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $66.5 million in Q4 2023 and bottomed at -$134.1 million in Q4 2025.
- Historically, Net Cash Flow has averaged $8.1 million across 5 years, with a median of $17.4 million in 2022.
- Annual changes were most pronounced in 2023 — Net Cash Flow jumped 323.19% — and 2025, when it sank 1103.06%.
- Penumbra's Net Cash Flow stood at $15.7 million in 2022, then surged by 323.19% to $66.5 million in 2023, then slumped by 30.45% to $46.2 million in 2024, then slumped by 390.14% to -$134.1 million in 2025, then jumped by 73.17% to -$36.0 million in 2026.
- Business Quant data shows PEN's Net Cash Flow at -$36.0 million in Q2 2026, $54.4 million in Q1 2026, and -$134.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.79 Bn | 195.19 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.96 Bn | 122.49 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.43 Bn | 109.21 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 73.13 Bn | 72.59 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.63 Bn | 47.38 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.71 Bn | 31.60 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.17 Bn | 22.85 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Penumbra | 12.77 Bn | 12.11 Bn | 264.94 Mn | -35.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.98 Mn |
| Jun 30, 2026 | -35.98 Mn |
| Mar 31, 2026 | 54.43 Mn |
| Mar 31, 2026 | 54.43 Mn |
| Dec 31, 2025 | -134.11 Mn |
| Dec 31, 2025 | -134.11 Mn |
| Sep 30, 2025 | -100.65 Mn |
| Sep 30, 2025 | -100.65 Mn |
| Jun 30, 2025 | 44.18 Mn |
| Jun 30, 2025 | 44.18 Mn |
| Mar 31, 2025 | 51.18 Mn |
| Mar 31, 2025 | 51.18 Mn |
| Dec 31, 2024 | 46.22 Mn |
| Dec 31, 2024 | 46.22 Mn |
| Sep 30, 2024 | -8.37 Mn |
| Sep 30, 2024 | -8.37 Mn |
| Jun 30, 2024 | 65.36 Mn |
| Jun 30, 2024 | 65.36 Mn |
| Mar 31, 2024 | 55.89 Mn |
| Mar 31, 2024 | 55.89 Mn |